See more : Sure Global Tech Company (9550.SR) Income Statement Analysis – Financial Results
Complete financial analysis of The Pennant Group, Inc. (PNTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Pennant Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- NAHL Group Plc (NAH.L) Income Statement Analysis – Financial Results
- Sajo Industries Company Limited (007160.KS) Income Statement Analysis – Financial Results
- JSS Corporation (6074.T) Income Statement Analysis – Financial Results
- Directel Holdings Limited (8337.HK) Income Statement Analysis – Financial Results
- NIPPON KANZAI Holdings Co.,Ltd. (9347.T) Income Statement Analysis – Financial Results
The Pennant Group, Inc. (PNTG)
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 544.89M | 473.24M | 439.69M | 390.95M | 338.53M | 286.06M | 250.99M | 217.23M |
| Cost of Revenue | 477.86M | 414.66M | 393.96M | 336.07M | 293.92M | 243.62M | 218.58M | 188.94M |
| Gross Profit | 67.04M | 58.59M | 45.74M | 54.89M | 44.62M | 42.44M | 32.41M | 28.29M |
| Gross Profit Ratio | 12.30% | 12.38% | 10.40% | 14.04% | 13.18% | 14.84% | 12.91% | 13.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Other Expenses | 0.00 | 4.90M | 4.78M | 4.68M | 3.81M | 2.96M | 2.54M | 2.86M |
| Operating Expenses | 41.87M | 38.88M | 41.04M | 35.97M | 38.95M | 21.81M | 17.01M | 15.30M |
| Cost & Expenses | 519.72M | 453.54M | 435.00M | 372.04M | 332.86M | 265.43M | 235.59M | 204.24M |
| Interest Income | 0.00 | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.92M | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.13M | 4.90M | 4.78M | 4.68M | 4.03M | 2.96M | 2.54M | 2.86M |
| EBITDA | 30.64M | 24.60M | 9.46M | 23.82M | 9.48M | 23.60M | 17.95M | 15.84M |
| EBITDA Ratio | 5.62% | 5.19% | 2.15% | 6.09% | 2.80% | 8.25% | 7.15% | 7.29% |
| Operating Income | 25.17M | 19.67M | 4.70M | 18.92M | 5.67M | 20.63M | 15.40M | 12.98M |
| Operating Income Ratio | 4.62% | 4.16% | 1.07% | 4.84% | 1.67% | 7.21% | 6.14% | 5.98% |
| Total Other Income/Expenses | -5.59M | -3.85M | -1.97M | -1.01M | -410.00K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 19.58M | 8.89M | 2.73M | 17.90M | 5.26M | 20.63M | 15.40M | 12.98M |
| Income Before Tax Ratio | 3.59% | 1.88% | 0.62% | 4.58% | 1.55% | 7.21% | 6.14% | 5.98% |
| Income Tax Expense | 5.67M | 1.65M | 582.00K | 2.35M | 2.09M | 4.35M | 5.38M | 5.07M |
| Net Income | 13.38M | 6.64M | 2.15M | 15.74M | 2.55M | 15.68M | 9.87M | 7.89M |
| Net Income Ratio | 2.46% | 1.40% | 0.49% | 4.03% | 0.75% | 5.48% | 3.93% | 3.63% |
| EPS | 0.45 | 0.23 | 0.08 | 0.56 | 0.09 | 0.56 | 0.35 | 0.28 |
| EPS Diluted | 0.44 | 0.22 | 0.07 | 0.52 | 0.09 | 0.56 | 0.35 | 0.28 |
| Weighted Avg Shares Out | 29.86M | 29.06M | 28.41M | 28.03M | 27.84M | 27.83M | 27.83M | 28.00M |
| Weighted Avg Shares Out (Dil) | 30.19M | 30.16M | 30.64M | 30.23M | 29.59M | 28.00M | 28.00M | 28.00M |
DGX vs. PNTG: Which Stock Is the Better Value Option?
Pennant Announces Second Quarter 2024 Earnings Release and Call
Pennant Announces Agreement to Purchase the Assets of Signature Healthcare at Home
Gold Price Forecast: Volatility Looms as Pennant Pattern Develops
Gold Price Forecast: Bear Pennant Signals Possible Decline
Pennant and Hartford HealthCare Partner to Transform Home Care Services
The Pennant Group, Inc. (PNTG) is a Great Momentum Stock: Should You Buy?
Pennant Acquires South Texas Hospice Provider
Pennant Group to Participate in the 2024 RBC Global Healthcare Conference
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
Source: https://incomestatements.info
Category: Stock Reports